DK4215621T3 - Kvantificering af nukleosommodificeringer ved anvendelse af kemisk definerede rekombinante nukleosomer - Google Patents

Kvantificering af nukleosommodificeringer ved anvendelse af kemisk definerede rekombinante nukleosomer

Info

Publication number
DK4215621T3
DK4215621T3 DK23157465.8T DK23157465T DK4215621T3 DK 4215621 T3 DK4215621 T3 DK 4215621T3 DK 23157465 T DK23157465 T DK 23157465T DK 4215621 T3 DK4215621 T3 DK 4215621T3
Authority
DK
Denmark
Prior art keywords
quantification
chemically defined
defined recombinant
nucleosome modifications
recombinant nucleosomes
Prior art date
Application number
DK23157465.8T
Other languages
Danish (da)
English (en)
Inventor
Andrea L Johnstone
Martis William Cowles
Matthew F Whelihan
Matthew R Marunde
Michael-Christopher Koegh
Nathan W Hall
Zu-Wen Sun
Original Assignee
Epicypher Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicypher Inc filed Critical Epicypher Inc
Application granted granted Critical
Publication of DK4215621T3 publication Critical patent/DK4215621T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/31—Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.1.31)
    • C12Y301/31001—Micrococcal nuclease (3.1.31.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/18—Post-translational modifications [PTMs] in chemical analysis of biological material citrullination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Ecology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK23157465.8T 2018-03-01 2019-03-01 Kvantificering af nukleosommodificeringer ved anvendelse af kemisk definerede rekombinante nukleosomer DK4215621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862637066P 2018-03-01 2018-03-01
EP19760658.5A EP3759249B1 (en) 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes

Publications (1)

Publication Number Publication Date
DK4215621T3 true DK4215621T3 (da) 2025-08-04

Family

ID=67805943

Family Applications (2)

Application Number Title Priority Date Filing Date
DK23157465.8T DK4215621T3 (da) 2018-03-01 2019-03-01 Kvantificering af nukleosommodificeringer ved anvendelse af kemisk definerede rekombinante nukleosomer
DK19760658.5T DK3759249T3 (da) 2018-03-01 2019-03-01 Kvantificering af nukleosommodifikationer ved anvendelse af kemisk definerede rekombinante nukleosomer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19760658.5T DK3759249T3 (da) 2018-03-01 2019-03-01 Kvantificering af nukleosommodifikationer ved anvendelse af kemisk definerede rekombinante nukleosomer

Country Status (10)

Country Link
US (2) US10787697B2 (cg-RX-API-DMAC7.html)
EP (2) EP3759249B1 (cg-RX-API-DMAC7.html)
JP (1) JP7376493B2 (cg-RX-API-DMAC7.html)
CN (1) CN111918971B (cg-RX-API-DMAC7.html)
AU (1) AU2019228625B2 (cg-RX-API-DMAC7.html)
CA (1) CA3091807A1 (cg-RX-API-DMAC7.html)
DK (2) DK4215621T3 (cg-RX-API-DMAC7.html)
ES (2) ES2960550T3 (cg-RX-API-DMAC7.html)
FI (2) FI3759249T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019169263A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230003735A1 (en) * 2019-12-02 2023-01-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
US12636417B2 (en) 2020-09-21 2026-05-26 Belgian Volition Srl Device for inline monitoring of free nucleosomes in blood
CN112359092B (zh) * 2020-10-22 2023-09-19 中国农业科学院农业基因组研究所 一种基因组短片段文库的构建方法
CA3195344A1 (en) * 2020-11-02 2022-05-05 Matthew R. MARUNDE Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion
GB202108185D0 (en) * 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
WO2023159045A1 (en) * 2022-02-15 2023-08-24 Epicypher, Inc. Engineered recombinant protein-binding domains as detection reagents
WO2024042208A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for the detection of dementia
EP4602370A1 (en) * 2022-10-12 2025-08-20 Epicypher, Inc. High efficiency antibodies for chromatin targets
EP4639173A1 (en) * 2022-12-19 2025-10-29 Belgian Volition SRL Calibration
EP4689160A1 (en) * 2023-04-03 2026-02-11 Belgian Volition SRL Recombinant nucleosome materials

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1008748A (en) 1910-06-15 1911-11-14 Christian Keene Snavely Shade-roller.
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2011016869A1 (en) 2009-08-06 2011-02-10 Kamran Tahamtanzadeh Methods and compositions for drug discovery
EP2621942A4 (en) * 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
GB201115099D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2859139B1 (en) 2012-06-06 2018-08-01 The Trustees Of Princeton University Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
US9745384B2 (en) * 2012-12-20 2017-08-29 The Brigham And Women's Hospital, Inc. Peptides useful for modulating histone demethylase function
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes
GB201400522D0 (en) * 2014-01-13 2014-02-26 Proteros Biostructure Gmbh Nucleosome substrate assays
EP3102721B1 (en) * 2014-02-03 2020-04-15 The University of Chicago Compositions and methods for quantitative assesment of dna-protein complex density
GB201511512D0 (en) 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
WO2017034970A1 (en) * 2015-08-21 2017-03-02 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
GB201518665D0 (en) * 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
EP3371601A1 (en) 2015-11-05 2018-09-12 Epizyme Inc Flow cytometry for monitoring histone h3 methylation status

Also Published As

Publication number Publication date
US10787697B2 (en) 2020-09-29
JP2021515888A (ja) 2021-06-24
CN111918971A (zh) 2020-11-10
EP4215621A1 (en) 2023-07-26
CA3091807A1 (en) 2019-09-06
EP3759249B1 (en) 2023-08-30
ES3036655T3 (en) 2025-09-23
CN111918971B (zh) 2024-09-03
EP4215621B1 (en) 2025-05-28
US20200071745A1 (en) 2020-03-05
ES2960550T3 (es) 2024-03-05
AU2019228625A1 (en) 2020-09-03
FI3759249T3 (fi) 2023-10-11
US20210010058A1 (en) 2021-01-14
FI4215621T3 (fi) 2025-07-28
EP3759249A1 (en) 2021-01-06
US12104199B2 (en) 2024-10-01
DK3759249T3 (da) 2023-10-30
JP7376493B2 (ja) 2023-11-08
WO2019169263A1 (en) 2019-09-06
AU2019228625B2 (en) 2024-11-07
EP3759249A4 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
DK3759249T3 (da) Kvantificering af nukleosommodifikationer ved anvendelse af kemisk definerede rekombinante nukleosomer
EP3903448A4 (en) PREDICTION OF USE OR COMPLIANCE
IL289349A (en) Firmware management for iot devices
EP4069212A4 (en) INHIBITORS OF HIF-2ALPHA
EP3857879A4 (en) SIMPLIFICATION OF COMBINED INTER-INTRA PREDICTION
EP3815005A4 (en) Transcription factor profiling
EP4048010C0 (en) BANDWIDTH PORTION SWITCHING
EP3801500A4 (en) Inhibitors of sarm1
EP3773896A4 (en) CONTROLLED RELEASE OF RADIONUKLIDES
EP3946717C0 (en) MICROWAVE PYROLYSIS REACTOR
IL289197A (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
EP3918492A4 (en) Managing geospatial boundaries
DK3517543T3 (da) Fremstilling af glucagonpeptider
EP3874906C0 (en) RESOURCE GROUP ASSIGNMENT
EP3983360C0 (en) STRUVITE DECOMPOSITION
EP3776545A4 (en) QUANTIZATION OF SPATIAL AUDIO PARAMETERS
DK3743064T3 (da) Behandling af proteinuri
IL285119A (en) Use of spiropidion
DK3833378T3 (da) Behandling af vorter
EP3870331C0 (en) ALTERATION OF FCRN ANTIBODY BINDING
EP3646032C0 (en) POLYSORBATE QUATIFICATION PROCESS
UA41506S (uk) Мікрохвильова піч
EP3861780A4 (en) COMPUTER RESOURCE UTILIZATION REDUCTION DEVICES
EP3453351A4 (en) POROUS TANTAL METAL SCREW FOR FASTENING BROKEN BONES AND APPLICATION THEREOF